nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—chronic kidney failure	0.818	1	CbGaD
Ximelagatran—F2—cardial valve—chronic kidney failure	0.038	0.374	CbGeAlD
Ximelagatran—CYP2C9—cardial valve—chronic kidney failure	0.0151	0.149	CbGeAlD
Ximelagatran—F2—vein—chronic kidney failure	0.014	0.138	CbGeAlD
Ximelagatran—F2—urine—chronic kidney failure	0.00819	0.0808	CbGeAlD
Ximelagatran—F2—artery—chronic kidney failure	0.0057	0.0562	CbGeAlD
Ximelagatran—F2—blood plasma—chronic kidney failure	0.00427	0.0421	CbGeAlD
Ximelagatran—CYP2C9—urine—chronic kidney failure	0.00326	0.0322	CbGeAlD
Ximelagatran—F2—renal system—chronic kidney failure	0.002	0.0198	CbGeAlD
Ximelagatran—F2—cardiovascular system—chronic kidney failure	0.00198	0.0195	CbGeAlD
Ximelagatran—F2—kidney—chronic kidney failure	0.00194	0.0191	CbGeAlD
Ximelagatran—CYP2C9—blood plasma—chronic kidney failure	0.0017	0.0168	CbGeAlD
Ximelagatran—F2—digestive system—chronic kidney failure	0.00164	0.0162	CbGeAlD
Ximelagatran—F2—blood—chronic kidney failure	0.00157	0.0154	CbGeAlD
Ximelagatran—CYP2C9—cardiovascular system—chronic kidney failure	0.000789	0.00778	CbGeAlD
Ximelagatran—CYP2C9—digestive system—chronic kidney failure	0.000655	0.00646	CbGeAlD
Ximelagatran—CYP2C9—blood—chronic kidney failure	0.000624	0.00615	CbGeAlD
Ximelagatran—F2—Hemostasis—OLR1—chronic kidney failure	0.000342	0.00424	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.000336	0.00418	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SERPINE1—chronic kidney failure	0.000333	0.00413	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL1B—chronic kidney failure	0.000332	0.00413	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ALB—chronic kidney failure	0.000332	0.00413	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—NPS—chronic kidney failure	0.00033	0.0041	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.000328	0.00407	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—NPS—chronic kidney failure	0.000325	0.00404	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ICAM1—chronic kidney failure	0.000316	0.00393	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—chronic kidney failure	0.000315	0.00391	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—chronic kidney failure	0.000311	0.00386	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—NFKB1—chronic kidney failure	0.00031	0.00385	CbGpPWpGaD
Ximelagatran—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—chronic kidney failure	0.000308	0.00382	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.000308	0.00382	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—RELA—chronic kidney failure	0.000299	0.00372	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—chronic kidney failure	0.000295	0.00366	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.000293	0.00364	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.000291	0.00361	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.000287	0.00356	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.000284	0.00353	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—CCL2—chronic kidney failure	0.000283	0.00352	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SLC7A9—chronic kidney failure	0.000283	0.00352	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—chronic kidney failure	0.00027	0.00336	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SERPINE1—chronic kidney failure	0.000264	0.00328	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ALB—chronic kidney failure	0.000264	0.00328	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—NFKB1—chronic kidney failure	0.000252	0.00313	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000247	0.00307	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—chronic kidney failure	0.000246	0.00305	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic kidney failure	0.000245	0.00304	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—chronic kidney failure	0.000241	0.003	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—NPY—chronic kidney failure	0.000239	0.00297	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—AVP—chronic kidney failure	0.000238	0.00296	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—RELA—chronic kidney failure	0.000238	0.00295	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000236	0.00293	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—AVP—chronic kidney failure	0.000235	0.00292	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—chronic kidney failure	0.000231	0.00287	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—OXT—chronic kidney failure	0.00023	0.00286	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—chronic kidney failure	0.00023	0.00286	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CRHR1—chronic kidney failure	0.000229	0.00284	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—chronic kidney failure	0.000227	0.00282	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—EDN1—chronic kidney failure	0.000227	0.00282	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—EDN1—chronic kidney failure	0.000224	0.00278	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL5—chronic kidney failure	0.000222	0.00276	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—NPS—chronic kidney failure	0.000218	0.00271	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.000216	0.00268	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—chronic kidney failure	0.000215	0.00267	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—chronic kidney failure	0.000214	0.00266	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—chronic kidney failure	0.000213	0.00265	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTH—chronic kidney failure	0.000209	0.0026	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic kidney failure	0.000203	0.00252	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—NFKB1—chronic kidney failure	0.0002	0.00249	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR5—chronic kidney failure	0.0002	0.00249	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	0.000198	0.00246	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—chronic kidney failure	0.000196	0.00244	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—chronic kidney failure	0.000195	0.00242	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	0.000186	0.00232	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—NPY—chronic kidney failure	0.000182	0.00226	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—OXT—chronic kidney failure	0.000175	0.00218	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CRH—chronic kidney failure	0.000175	0.00218	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2B6—chronic kidney failure	0.000174	0.00216	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.000172	0.00213	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.000171	0.00213	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.000169	0.0021	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—REN—chronic kidney failure	0.000169	0.0021	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—NPS—chronic kidney failure	0.000166	0.00207	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD1—chronic kidney failure	0.000163	0.00203	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—chronic kidney failure	0.000158	0.00197	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.000158	0.00196	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—POMC—chronic kidney failure	0.000156	0.00194	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—chronic kidney failure	0.000156	0.00194	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL2—chronic kidney failure	0.000153	0.0019	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2C18—chronic kidney failure	0.000151	0.00188	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.00015	0.00187	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.000149	0.00185	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000149	0.00185	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—KRAS—chronic kidney failure	0.000141	0.00175	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000139	0.00173	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.000134	0.00167	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF1—chronic kidney failure	0.000133	0.00166	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS1—chronic kidney failure	0.00013	0.00161	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CRHR1—chronic kidney failure	0.000129	0.00161	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.000128	0.00159	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SERPINE1—chronic kidney failure	0.000127	0.00157	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ALB—chronic kidney failure	0.000126	0.00157	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—chronic kidney failure	0.000126	0.00156	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2C19—chronic kidney failure	0.000125	0.00155	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.000123	0.00153	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—AVP—chronic kidney failure	0.00012	0.00149	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTH—chronic kidney failure	0.000118	0.00147	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—chronic kidney failure	0.000118	0.00146	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CRHR1—chronic kidney failure	0.000117	0.00146	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.000116	0.00145	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—PTGS1—chronic kidney failure	0.000114	0.00142	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—EDN1—chronic kidney failure	0.000114	0.00142	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL5—chronic kidney failure	0.000113	0.00141	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTH—chronic kidney failure	0.000107	0.00133	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE—chronic kidney failure	0.000105	0.00131	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.000105	0.0013	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.000104	0.00129	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NPY—chronic kidney failure	0.000103	0.00128	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.000103	0.00128	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR5—chronic kidney failure	0.000102	0.00127	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—chronic kidney failure	0.000101	0.00126	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.000101	0.00125	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CRH—chronic kidney failure	9.91e-05	0.00123	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—OXT—chronic kidney failure	9.91e-05	0.00123	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP3A4—chronic kidney failure	9.9e-05	0.00123	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—COL4A5—chronic kidney failure	9.85e-05	0.00122	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP3A4—chronic kidney failure	9.76e-05	0.00121	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NPS—chronic kidney failure	9.4e-05	0.00117	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NPY—chronic kidney failure	9.33e-05	0.00116	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD1—chronic kidney failure	9.21e-05	0.00114	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TFDP2—chronic kidney failure	9.15e-05	0.00114	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—OXT—chronic kidney failure	9e-05	0.00112	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CRH—chronic kidney failure	9e-05	0.00112	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIP5K1B—chronic kidney failure	8.96e-05	0.00111	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—chronic kidney failure	8.71e-05	0.00108	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NPS—chronic kidney failure	8.53e-05	0.00106	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAU—chronic kidney failure	8.43e-05	0.00105	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD1—chronic kidney failure	8.37e-05	0.00104	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PGF—chronic kidney failure	8.16e-05	0.00101	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—chronic kidney failure	7.99e-05	0.000993	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—POMC—chronic kidney failure	7.99e-05	0.000992	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	7.98e-05	0.000992	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL2—chronic kidney failure	7.82e-05	0.000971	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	7.81e-05	0.000971	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKAG2—chronic kidney failure	7.67e-05	0.000953	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	7.57e-05	0.00094	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	7.51e-05	0.000932	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A1—chronic kidney failure	7.38e-05	0.000916	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A1—chronic kidney failure	7.28e-05	0.000904	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—COL4A3—chronic kidney failure	7.27e-05	0.000903	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HBEGF—chronic kidney failure	7.11e-05	0.000884	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CRHR1—chronic kidney failure	6.94e-05	0.000862	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF1—chronic kidney failure	6.87e-05	0.000854	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AVP—chronic kidney failure	6.79e-05	0.000844	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	6.69e-05	0.000831	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	6.69e-05	0.000831	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LRP2—chronic kidney failure	6.65e-05	0.000826	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINE1—chronic kidney failure	6.52e-05	0.000811	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—chronic kidney failure	6.51e-05	0.000809	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—EDN1—chronic kidney failure	6.46e-05	0.000803	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCL5—chronic kidney failure	6.41e-05	0.000796	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTH—chronic kidney failure	6.34e-05	0.000788	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	6.26e-05	0.000778	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS3—chronic kidney failure	6.23e-05	0.000774	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CYBB—chronic kidney failure	6.18e-05	0.000768	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AVP—chronic kidney failure	6.17e-05	0.000766	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	6.16e-05	0.000765	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	6.05e-05	0.000752	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	5.92e-05	0.000736	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EDN1—chronic kidney failure	5.87e-05	0.000729	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF23—chronic kidney failure	5.86e-05	0.000727	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL5—chronic kidney failure	5.82e-05	0.000723	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	5.8e-05	0.000721	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR5—chronic kidney failure	5.78e-05	0.000718	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—POMC—chronic kidney failure	5.62e-05	0.000698	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPY—chronic kidney failure	5.51e-05	0.000685	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—POMC—chronic kidney failure	5.5e-05	0.000683	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CCL2—chronic kidney failure	5.5e-05	0.000683	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—chronic kidney failure	5.4e-05	0.000671	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CRH—chronic kidney failure	5.32e-05	0.000661	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OXT—chronic kidney failure	5.32e-05	0.000661	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR5—chronic kidney failure	5.25e-05	0.000652	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FABP1—chronic kidney failure	5.19e-05	0.000644	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NCF1—chronic kidney failure	5.09e-05	0.000633	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPS—chronic kidney failure	5.04e-05	0.000626	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD1—chronic kidney failure	4.94e-05	0.000614	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	4.93e-05	0.000613	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AGXT—chronic kidney failure	4.92e-05	0.000611	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GATM—chronic kidney failure	4.92e-05	0.000611	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	4.81e-05	0.000597	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	4.81e-05	0.000597	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CYBA—chronic kidney failure	4.79e-05	0.000595	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—POMC—chronic kidney failure	4.51e-05	0.000561	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACAT1—chronic kidney failure	4.5e-05	0.000559	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—chronic kidney failure	4.49e-05	0.000558	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	4.44e-05	0.000552	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	4.4e-05	0.000546	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	4.31e-05	0.000536	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HBEGF—chronic kidney failure	4.2e-05	0.000522	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	4.19e-05	0.000521	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	4.18e-05	0.000519	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—chronic kidney failure	4.12e-05	0.000512	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	4.1e-05	0.00051	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—POMC—chronic kidney failure	4.1e-05	0.000509	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL2—chronic kidney failure	4.01e-05	0.000498	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	3.82e-05	0.000475	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—chronic kidney failure	3.82e-05	0.000474	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	3.74e-05	0.000464	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AVP—chronic kidney failure	3.64e-05	0.000453	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG1—chronic kidney failure	3.56e-05	0.000442	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	3.48e-05	0.000432	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDN1—chronic kidney failure	3.47e-05	0.000431	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL5—chronic kidney failure	3.44e-05	0.000427	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ARG2—chronic kidney failure	3.41e-05	0.000423	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LPL—chronic kidney failure	3.36e-05	0.000418	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LCAT—chronic kidney failure	3.34e-05	0.000415	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGF—chronic kidney failure	3.19e-05	0.000396	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR5—chronic kidney failure	3.1e-05	0.000385	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DDC—chronic kidney failure	3.07e-05	0.000381	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	2.98e-05	0.00037	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PRKD1—chronic kidney failure	2.98e-05	0.00037	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	2.98e-05	0.00037	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.93e-05	0.000364	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.83e-05	0.000352	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SREBF2—chronic kidney failure	2.79e-05	0.000347	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCC3—chronic kidney failure	2.69e-05	0.000335	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCKR—chronic kidney failure	2.69e-05	0.000335	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPIN1—chronic kidney failure	2.64e-05	0.000328	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.59e-05	0.000322	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	2.58e-05	0.000321	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LRP2—chronic kidney failure	2.58e-05	0.000321	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IRS1—chronic kidney failure	2.51e-05	0.000312	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—POMC—chronic kidney failure	2.42e-05	0.000301	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL2—chronic kidney failure	2.37e-05	0.000294	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—chronic kidney failure	2.33e-05	0.000289	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SERPINE1—chronic kidney failure	2.21e-05	0.000275	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CPT1A—chronic kidney failure	2.2e-05	0.000273	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—chronic kidney failure	2.19e-05	0.000272	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LIPC—chronic kidney failure	2.14e-05	0.000266	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	2.14e-05	0.000266	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.11e-05	0.000262	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—chronic kidney failure	2.11e-05	0.000262	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RELA—chronic kidney failure	1.99e-05	0.000247	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SCARB1—chronic kidney failure	1.98e-05	0.000246	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS1—chronic kidney failure	1.96e-05	0.000243	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.93e-05	0.000239	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SREBF1—chronic kidney failure	1.92e-05	0.000239	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMGCR—chronic kidney failure	1.87e-05	0.000232	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FASN—chronic kidney failure	1.83e-05	0.000227	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—chronic kidney failure	1.78e-05	0.000221	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	1.69e-05	0.00021	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.68e-05	0.000209	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFKB1—chronic kidney failure	1.68e-05	0.000208	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCA1—chronic kidney failure	1.66e-05	0.000207	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—chronic kidney failure	1.52e-05	0.000189	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAT—chronic kidney failure	1.41e-05	0.000175	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—chronic kidney failure	1.4e-05	0.000173	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCB1—chronic kidney failure	1.37e-05	0.00017	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPL—chronic kidney failure	1.31e-05	0.000162	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—chronic kidney failure	1.29e-05	0.000161	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	1.26e-05	0.000157	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—chronic kidney failure	1.18e-05	0.000146	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARA—chronic kidney failure	1.15e-05	0.000143	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—chronic kidney failure	1.05e-05	0.000131	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—POMC—chronic kidney failure	9.41e-06	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—chronic kidney failure	8.58e-06	0.000107	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—chronic kidney failure	8.2e-06	0.000102	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—chronic kidney failure	7.5e-06	9.32e-05	CbGpPWpGaD
